21 March 2023
Cambridge Cognition Holdings plc
("Cambridge Cognition", the "Company" or the "Group")
Block Admission Application
Exercise of Options and PDMR Dealing
Cambridge Cognition Holdings plc (AIM: COG), which develops and markets digital solutions to assess brain health, announces that an application has been made to the London Stock Exchange for a block admission of 1,000,000 ordinary shares of £0.01 each ("Ordinary Shares") to be admitted to trading on AIM ("Block Admission").
The Block Admission relates to Ordinary Shares that will be issued from time to time in accordance with the exercise of options previously granted by the Company. All Ordinary Shares issued pursuant to the Block Admission above will rank pari passu with the existing Ordinary Shares.
It is expected that the Block Admission will become effective on or around 23 March 2023.
In addition, the Company has issued and allotted 199,701 new Ordinary Shares in the share capital of the Company following the exercise of 222,820 options on 16 March 2023 ("Option Exercise"). Of the options exercised, 90,000 were exercised utilising the net cashless exercise feature, resulting in 23,119 options being surrendered to the Company. The options were exercised pursuant to the Cambridge Cognition Holdings 2013 EMI Share Option Plan. The new Ordinary Shares will be admitted to trading pursuant to the Block Admission.
Included in the exercise of options were options over 119,534 Ordinary Shares held by PDMRs of the Company as detailed in the table below:
| Director/ PDMR | Position | Existing interest in Ordinary Shares | Number of Options over Ordinary Shares exercised | Resultant interest in Ordinary Shares | Rollover options remaining after exercise |
| Ricky Dolphin | Chief Technology Officer | - | 119,534 | 119,534 | - |
Total voting rights
Following the issue of the new Ordinary Shares pursuant to the Option Exercise, the total number of voting rights of the Company will be 34,815,389. This figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in Cambridge Cognition under the FCA's Disclosure and Transparency Rules.
The Company intends to notify on a monthly basis when there are changes to the issued share capital of the Company, and these monthly figures may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company, under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries:
| | |||||||||||||||||||||||||||||||||||||||||||||||||
| | | |||||||||||||||||||||||||||||||||||||||||||||||||
| | | |||||||||||||||||||||||||||||||||||||||||||||||||
| NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM:
| | |||||||||||||||||||||||||||||||||||||||||||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
